Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

PYPD
Polypid Ltd
stock NASDAQ

Market Open
5/30/2023 2:12:30 PM EDT
0.3701USD+5.743%(+0.0201)0
0.2880Bid   0.4330Ask   0.1450Spread IEX
Pre-market
5/30/2023 8:35:30 AM EDT
0.3509USD+0.257%(+0.0009)0
After-hours
5/22/2023 4:04:30 PM EDT
0.3632USD+1.851%(+0.0066)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
7.347M
Industry
Biotechnology
Next Earnings
2023-08-09 (71d)
PYPD Stats
Avg. Vol. 10 Day
140,788
Avg. Vol. 30 Day
89,861
Employees
57
Market Cap
7,347,163
Shares Out.
19,851,833
Float
16,722,902
On/Off Exchange
42%/58%
6 Month Beta
0.73
1 Year Beta
1.38
2 Year Beta
1.04
3 Year Beta
0.81
52 Week Low
0.33
52 Week High
6.90
SMA50
0.40
SMA200
0.64
1 Week
+5.68%
1 Month
-10.08%
3 Month
-46.36%
6 Month
-53.15%
1 Year
-93.12%
2 Year
-96.05%
Jan 26, 2022
07:30AM EST  PolyPid to Report Fourth Quarter and Full Year 2021 Financial   GlobeNewswire Inc
Jan 4, 2022
07:30AM EST  PolyPid Appoints UCSF Brain Tumor Center Director Mitchel S.   GlobeNewswire Inc
Jan 3, 2022
08:17AM EST  PolyPid Ltd. (PYPD), an Israeli biopharmaceutical firm, said on Monday that its Chief Executive Officer or CEO Amir Weisberg, will retire from the service with effect from July 1.   RTTNews
07:37AM EST  PolyPid Appoints Dikla Czaczkes Akselbrad As CEO, Effective July 1   RTTNews
07:31AM EST  PolyPid Appoints Dikla Czaczkes Akselbrad CEO   Benzinga
More News
Profile
PolyPid Ltd. is a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics. PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with medications, enables precise delivery of drugs at effective release rates, over durations ranging from several days to months. PolyPid's lead product candidate D-PLEX100 is in Phase 3 clinical trials for the prevention of sternal and abdominal surgical site infections (SSIs).

PYPD Stock Summary

Polypid Ltd (NASDAQ:PYPD) stock price today is $0.3701, and today's volume is 0. PYPD is up 5.743% today. The 30 day average volume is 89,861. PYPD market cap is 7.347M with 19,851,833 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC